Cardiovascular II Part 2
PVCPremature Ventricular Contraction
2
PVCPremature Ventricular Contraction
• Premature ventricular contracture• With a PVC, diastolic volume is insufficient
for ejection of blood into arterial system. – Therefore, no or weak pulse palpated.
• Few/day = OK, More/minute, the worse (>6). • Common post MI, SNS activity, K+,
hypoxia.
3
V-FibVentricular Fibrillation
4
V-FibVentricular Fibrillation
• Ventricle quivers but does NOT contract! – NO cardiac output and no pulses
• Cardiac Arrest!!
• Grossly disorganized pattern
5
V-TachVentricular Tachycardia
6
V-TachVentricular Tachycardia
• A bunch of PVC in a row– Rhythm originates below Bundle of His, in ventricular
muscle. • It is too fast, so ventricular filling is ineffective and CO is ineffective
• Wide, tall QRS complexes• Stops spontaneously or continues• Dangerous rhythm, diastolic filling time CO• Can cause Cardiac Arrest
7
Class I AntidysrhythmicsDiagram
8
Lehne 5th ed Figure 47-2
Myocardium& His-Purkinje
System
SA Node &AV Node
9
Class I Antidysrhythmic
Class 1B: Lidocaine Ventricular Dysrhthmias
10
Class 1B: Lidocaine Ventricular Dysrhythmias
11
Class 1B: LidocaineEffects on the Heart and the ECG
12
Class 1B: LidocaineEffects on the Heart and the ECG
1. Blocks Na+ channels slow conduction thru atria, ventricles, HIS-Purkinje
2. Reduces automaticity-Slows the heart rate down
3. Accelerates repolarization (shortens action potential)• No anticholinergic effect• No change in ECG
– See a restoration of sinus normal
13
LidocainePrecautions and Adverse Effects
14
LidocainePrecautions and Adverse Effects
• Metabolized by Liver• Therapeutic range 1.5 – 5.0 microgm/ml
– Pretty narrow• Adverse CNS Effects
– Drowsiness, confusion, paresthesia• Toxicity
– Convulsions and respiratory arrest
15
LidocaineAdministration
16
LidocaineAdministration
• IV Push–50-100mg (1mg/kg)–Comes in a preloaded syringe
• Infusion–1-4mg/min–Diluted in D5W
• Special Considerations–Use for as short a time as possible–Reduce dosage in pts with liver disorders
17
Class III AntidysrhythmicsPotassium Channel Blockers
18
Class III Antidysrhythmic• Potassium Channel Blockers: Amiodarone• Approved for V-tach and V-fib.• Delay repolarization of the ventricles Prolongs action potential and refractory period
Increases PR and QT intervals- as the QT interval lengthens, the person may develop additional dysrhythmias
19
Initial catecholamine release brief exacerbation of dysrhythmias
- Catecholamines speed up the heart and lead to stronger heart beatsblock catecholamine release vasodilation /
hypotension
Lehne 5th ed Figure 47-2
Myocardium& His-Purkinje
System
SA Node &AV Node
20
Class III Antidysrhythmic
Non-Pharmacologic Treatment of Dysrhythmias
21
Non-Pharmacologic Treatment of Dysrhythmias
• Cardioversion– Synchronized,
coordinated shocking of the heart
– Atrial fib– V-tach
• Defibrillation– A shock that is
delivered as soon as the buttons are pushed
– V-fib
22
Automated External Defibrillator
23
Automated External Defibrillator• Cardiac Arrest, AED “interrogates” rhythm.
– Waits to see what the rhythm is and then delivers the shock as needed (timed for V-tach and not timed for V-fib.)
• Tells user what to do, eg. “Shock Now”• Delivers shock for V-tach or V-fib.
24
Implantable Cardioverter/Defibrillator
25
Implantable Cardioverter/Defibrillator
• Like a pacemaker
• Monitors and analyzes rhythm
• Delivers shock to terminate V-tach, V-fib
26
Radiofrequency Catheter Ablation
27
Radiofrequency Catheter Ablation
• Cardiac cath and electrophysiologic (EP) test• Identify cardiac tissue site which causes
dysrhythmia while in the cath lab– Map the myocardium
• RF energy delivered to destroy the tissue so that that focus/area does not fire anymore– Remember, you can’t pace meatloaf
• Dead myocardium or heart tissue will not respond to pacing
28
Antidysrhythmic DrugsSummary
29
Antidysrhythmic DrugsSummary
• Class I –Depress phase 0 in depolarization–Block sodium channels
• Class II (Beta-blockers)–Depress phase 4 in depolarization–Block beta 1 & 2 adrenergic receptors
HR Contractility
30
Antidysrhythmic Drugs: Summary
• Class III (Potassium Channel Blockers)–Prolong phase 3 (repolarization)
• Class IV (Calcium Channel Blockers)–Depresses phase 4 depolarization–Prolongs phases 1 & 2 repolarization
31
Management of Cardiac Dysrhythmias
32
Management of Cardiac Dysrhythmias
REMEMBER:Many drugs used to treat dysrhythmias
also may worsen them or cause new ones!
33
CORONARY HEART DISEASE ANDACUTE MYOCARDIAL INFARCTION(MI OR AMI) 34
Coronary Circulation
35
Coronary Circulation• Two main coronary arteries
arise from coronary sinus (above aortic valve)– The orifices are above the
aorta• The heart perfuses during
diastole because it is when the coronary arteries are open
• Primary factor responsible for perfusion of coronary arteries is BP in aorta
• s aortic pressure -> s coronary blood flow
36
Coronary CirculationDiagram
37
LV LV
Coronary CirculationDiagram
38
Coronary Arteries
39
Coronary Arteries
• Right coronary artery– Nourishes right side, SA node, AV node – may lead to
heart block
• Left coronary artery– A block in the left coronary artery leads to death
because it sends blood to the left side of the heart and then to the body
– Left anterior descending– Left circumflex
40
41
ISCHEMIC HEART DISEASEA.K.A CORONARY HEART DISEASE A.K.A CORONARY ARTERY DISEASEANGINAMYOCARDIAL INFARCTION
42
Coronary Heart Disease
43
Coronary Heart Disease• Heart disease caused by impaired coronary blood
flow (atherosclerosis)
• Cause angina, dysrhythmias, conduction defects, heart failure, sudden death, myocardial infarction (“heart attack”)
• If blood flow is temporarily inadequate (due to increased oxygen demand), ischemia produces pain (angina).
• Myocardial Infarction is myocardial cell/tissue death due to oxygen starvation
44
Assessment of Coronary Blood Flow
45
Assessment of Coronary Blood Flow
• ECG• Exercise Stress Testing• Pharmacologic Stress Testing
–May give catecholamines, such as epinephrine, norepinephrine
• Nuclear Imaging• Cardiac Catheterization /Coronary angiography
46
Collateral Circulation
47
Collateral Circulation• With gradual occlusion of large coronary
vessels, the smaller collateral vessels in size and provide alternative channels for blood flow– Allow perfusion to the myocardium that is below
and is distal to the blood flow
• One of the reasons CHD does not produce symptoms until it is far advanced is that the collateral channels develop at the same time the atherosclerotic changes are occurring.
48
Collateral CirculationDiagram
49
50
Collateral CirculationDiagram
50
Pathogenesis of CAD Atherosclerosis
51
Pathogenesis of CAD Atherosclerosis
• Most common cause of CAD
• Plaque disruption is most the frequent cause of MI, sudden death
• Can affect one or all three major coronary arteries/branches
52
Plaque
53
Plaque• Plaques typically do not occlude the whole
coronary artery but produce a narrowing that restricts blood flow.– In times of increased oxygen demand, such as with
exercise, the restricted blood flow may produce ischemia in cells supplied by that artery.
– This produces the pain of angina.
54
Plaque Rupture
55
Plaque Rupture• A plaque may become unstable and rupture,
causing a clot to form which may completely occlude the artery.– Results in no bloodflow– Occlusion of the artery causes death of the cardiac
cells downstream that are supplied by that artery.– When the cells die, that is an infarction – hence the
name myocardial infarction.– Have about 90 minutes to restore the blood flow to
prevent permanent damage
56
Atherosclerosis in Coronary Artery
57
Atherosclerosis in Coronary ArteryPlaque rupture and disruption of atheroma lipid core/contents exposed to blood platelet aggregationcoagulation cascade fibrin clot
Give aspirin quickly to prevent or reduce the clotting
thrombosis, vasospasm myocardial ischemia Coronary arteries unable to supply blood to
meet metabolic demands of the heart58
Angina
59
Angina
• Angina: symptomatic paroxysmal chest pain or pressure sensation associated with transient myocardial ischemia
60
Stable Angina
61
Stable Angina
• Occurs with exertion or stress
• Predictable
• If plaque becomes unstable and ruptures, it leads to platelet aggregation and unstable angina
62
63
Variant or Vasospastic Angina
64
Variant or Vasospastic Angina
• Occurs during rest or with minimal activity (nocturnal, Prinzmetal’s)
65
Silent Myocardial Ischemia
66
Silent Myocardial Inschemia
• Occurs in the absence of anginal pain– Tend to be endocardial, in the inner layer of the
myocardium
67
Unstable Angina
68
Unstable Angina
• Symptoms at rest lasting >20 minutes
• Marked limitations of ordinary activity (walking 1–2 blocks, climbing a flight of stairs)
• Recent acceleration in anginal signs, not responsive to nitroglycerine
69
70
Acute Myocardial Infarction
71
Acute Myocardial Infarction
• Acute myocardial infarction (STEMI or NSTEMI)– ST segment elevation myocardium infarction
• STEMI - complete occlusion of bloodflow– Significant change on the EKG
• NSTEMI – partial occlusion of a blood vessel by a thrombus
72
73
74
Characteristics of Plaque Rupture
75
Characteristics of Plaque Rupture• Spontaneous
– SNS activation BP, HR, contraction– Triggering event (stress: emotional, physical)
• Diurnal– Plaque rupture is more common in the first hour
of arising– SNS “surge” on arising
• SNS major player– Beta-adrenergic blockers
• Block the adrenergic response so the patients will not have the same response to a SNS surge
76
“Severe” Coronary Stenosis and Vulnerable Plaques Co-exist
77
“Severe” Coronary Stenosis and Vulnerable Plaques Co-exist
78Califf, Atlas of Heart Diseases 2001
Ischemia, Injury, and Infarction
79
Ischemia, Injury, and Infarction Three Zones of Damage• Infarction = Necrosis
– MI, dead cells– Beyond hope of recovery but can stop
in from increasing• Injury
– Some recovery possible• Can still perfuse it and restore it to
become viable– Not dead yet
• Ischemia– Full recovery possible
• Do not want the patient to extend the size of the infarct– Increase oxygen– Decrease the demand on the heart
80
Zones of Tissue Damage
81
82
Zones of Tissue DamageGoal is to limit the area of necrosis (infarction) !
• Necrotic myocardial cells are gradually replaced with scar tissue • Scar tissue cannot contract or conduct action potentials, cannot respond to drugs or pacing
An Acute MI (AMI) Leaves Behind an Area of Yellow Necrosis
83
An Acute MI (AMI) Leaves Behind an Area of Yellow Necrosis
84
Pathologic Changes in Zones of Injury
85
Pathologic Changes in Zones of Injury
• Ischemic areas cease to function within minutes
• Irreversible damage/death to myocardial cells occurs within 20-40 minutes
• Early reperfusion (20min) after onset of ischemia can prevent necrosis, prevent further ischemia and necrosis
86
Extent of the Infarct
87
Extent of the Infarct
Extent of infarct depends on :• Location• Extent of occlusion • Amount of heart tissue supplied by vessel,
duration of occlusion• Metabolic needs of the affected tissue• Extent of collateral circulation
–A couch potato will probably have a lot more collateral circulation
88
Types of Infarct
89
Types of Infarct
• Transmural infarct– Full thickness of ventricular
wall, – Occurs with obstruction of a
single artery; – May involve RV, LV and/or IV
septum
• Subendocardial infarct– Involve inner 1/3 to 1/2
ventricular wall, – May occur with severely
narrowed arteries or with occlusion of a very small artery
90
Porth, 2007, Essential of Pathophysiology, 2nd ed., Lippincott, p. 328.
Types of Coronary Heart Disease
91
92
Chest Pain Assessment
93
Chest Pain Assessment• P – Provocation• Q – Quality
– Tell me about it...– Describe the pain
• R – Region/Radiation• S – Severity• T – Timing
– Does it occur at night or during the day– Predictability
94
Categories (PQRST)
95
Categories (PQRST)
• Angina that occurs with stress (physical/emotional)–Relieved within minutes by rest
or NTG (nitroglycerine)• Angina that occurs with rest• Is of new onset• Increasing intensity
96
risk forMI
Chronic Ischemic Heart Disease
97
98
Stable Angina
99
Stable Angina
• Fixed coronary obstruction• 02 Demand 02 supply pain
– Physical/emotional stress, cold• Provoked by stressor
– Relieved with rest/NTG (nitroglycerine)• Not everyone with CHD has angina
– Sedentary lifestyle (couch potatoes), development of collateral circulation, altered perception pain
100
Locations of Angina
101
Usual distribution of pain
Less common sites of pain distribution
Typically precordial, substernal
Angina
102
Variant or Vasospastic Angina
103
Variant or Vasospastic Angina• “Prinzmetal’s angina”
– Comes and goes without any predictability• Due to coronary artery spasms • Occurs during rest or with minimal exertion,
frequently nocturnal• Mechanism is uncertain
– Possibilities may include SNS activation, VSM Ca++ channel dysfunction, imbalance of endothelial cell vasodilating/constricting substances
• Dysrhythmias can occur– Person usually aware; High risk sudden death104
Variant or Vasospastic AnginaDiagram
105
Hamon M and Hamon M. N Engl J Med 2006;355:2236
A 38-year-old man was scheduled to undergo invasive coronary angiography after cardiac scintigraphy revealed silent ischemia of the anterior myocardial wall
Variant or Vasospastic AnginaDiagram
106
Acute Coronary Syndrome (ACS)
107
Acute Coronary Syndrome (ACS)
108
NSTEMI STEMI
Unstable or ruptured plaque
Acute Coronary Syndrome (ACS)
Unstable Angina
109
Acute Coronary Syndrome (ACS)Unstable Angina
110
Unstable Angina• Severe
• Clinical syndrome of myocardial ischemia ranging between stable angina and MI
• Usually due to atherosclerotic plaque disruption, platelet aggregation
111
Presentations of Unstable Angina
112
Presentations of Unstable Angina
1. Symptoms at rest (> 20 minutes)
2. Severe, frank pain, new onset (< 1month)- Pain crescendos
3. More severe, prolonged, or frequent
113
Porth, 2007, Essentials of Pathophysiology, 2nd ed., Lippincott, p. 392. 114
Acute Coronary Syndrome (ACS)ST-segment Elevation
115
Acute Coronary Syndrome (ACS)ST-segment Elevation
116
ST Segment Elevation
117
ST Segment Elevation• ST segment elevations are
indicative of myocardial damage or ischemia.
• It may take some time (minutes to hours) for the changes to show up, and they may not be present in all EKG leads.– The placement of the
leads and the occurrence of ST elevation indicates where the MI is occurring
118
Porth, 2007, Essentials of Pathophysiology, 2nd ed., Lippincott, p. 394.
ECGSTEMI vs. NSTEMI
119
ECGSTEMI vs. NSTEMI
120
Non ST Segment Elevation Myocardial Infarction (NSTEMI)
121
Non ST Segment Elevation Myocardial Infarction (NSTEMI)
• How is this different from unstable angina or STEMI?
• Unstable angina, plaque disruption but no thrombus or occlusion of the coronary artery, therefore no myocardial cell death (no MI).
• NSTEMI, a thrombus partially occludes a coronary artery. Depending on the degree of occlusion and oxygen demand of downstream heart cells, there may be myocardial cell death (an MI) but insufficient to produce ST segment elevations.• The patient may not have unstable angina• The amount of the infarction depends on how much blood flow is
getting through
122
Porth, 2007, Essentials of Pathophysiology, 2nd ed., Lippincott, p. 392. 123
ST Segment Elevation MI
124
ST Segment Elevation MI• Characterized by ischemia of cardiac tissue
• Area of infarction is determined by the coronary artery that is affected and by its distribution of blood flow–40-50% of time – LAD
• Influences CO, BP, and likelihood of survival or death
–30-40% of time – RCA• Will see blocks on the EKG due to SA
node or AV node dysfunction–15-20% of time - LCA
125
Porth, 2007, Essentials of Pathophysiology, 2nd ed., Lippincott, p. 392. 126
Diagnosis of CHD and MI
127
Diagnosis of CHD and MI• Good history and identification of risk
factors• R/O Other causes of CP, such as GERD• ECG• Serum myocardial markers• Stress testing
–May be exercise or pharmacological• Cardiac catheterization
128
“Classic” Manifestations of MI
129
“Classic” Manifestations of MI• Abrupt onset or progression of unstable,
non-ST elevation, which then moves to become ST elevation
• Pain is severe, crushing, “someone sitting on my chest”
• Radiates to left arm, jaw, neck• MI pain is prolonged, not relieved by rest
and/or NTG (unlike angina)• N/V, SNS activation HR, RR,
diaphoresis, cool/clammy skin130
ECG Changes
131
ECG Changes• T wave inversion• ST segment elevation• Abnormal Q wave
(may not appear immediately)– Wider and bigger where the MI
is present• Once a QI develops, it does
not ever go away• Changes can occur over
time, depending on duration of ischemia (extent and location)
• Changes may not be present in all leads – take 12-lead EKG– Will only be present over
the area that is infarcted
132
ST Segments
133
ST Segments
• 1st to change during ischemia or MI because myocardial repolarization is altered.
• Ischemia reduces membrane potential and shorten duration of AP in ischemic area.
134
Abnormal Q Waves
135
Abnormal Q Waves
• Develop because there is no depolarizing current conduction from necrotic tissue
• May not appear immediately
• Diagnostic of MI• Q waves are
permanent after MI
136
Serum Markers for Ischemia and MI
137
Serum Markers for Ischemia and MI
• Necrotic cells release intracellular enzymes into blood stream
• Measure these in blood– The larger the number, the larger the amount of necrotic
tissue–CK-MB (Creatine-kinase-myocardial bands)–Troponin–C-reactive Protein
• An inflammatory marker
138
CK-MB
139
CK-MB
• CK is normal in all muscle cells–Has three isoenzymes BB, MM, MB
• CK-MB Creatine kinase -myocardial bands is cardiac specific
• Elevated within 8 hours after MI• Returns to normal in 2-3 days• Nl ~ 24-195 IU/L
140
Troponin (TnC, TnI, TnT)
141
Troponin (TnC, TnI, TnT)• Very cardiac specific
– Most sensitive marker• Part of the actin-myosin filament• Elevate more quickly than the CK-MB
– Rises within 3 hours after MI– Remains elevated 3-4 days and up to 10 days
• Diagnostic of MI; No change with ischemia• Nl ~ 0.4 ng/ml
142
C-Reactive Protein (CRP)
143
C-Reactive Protein (CRP)• Marker of chronic inflammation• May be a marker of risk• Identifies people before they are
symptomatic• May guide preventative therapy in the
future• Non-specific because it increases with
any inflammatory response 144
Timeline of Cardiac Markers
145
Timeline of Cardiac Markers
146
Hr 1 2 3 4 5 6 7 8 9 10 11 12 Day 2 3 4 5
Troponin
CK-MB
Acute Coronary SyndromeConcept Map
147
NSTEMIUnstable angina
No ECG sElevation of serum markers, including troponin and CK-MB
Unstable AnginaPain is severeNo ECG sNo change in markers because they are not having an MI
ACS
No ST Elevation STEMI
148
InfarctionDiagram
149
150
Top Related